(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Rotator Cuff Injuries
Federal University of São PauloSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Rotator Cuff Injuries cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pregabalin The Catholic University of Korea | Phase 4 | BB |
DEXAMETHASONE Ankara City Hospital Bilkent | Phase 2 | CCC |
AUTOLOGOUS CONDITIONED PLASMA Kessler Foundation | Phase 1 | CC |
HUMAN AUTOLOGOUS ADIPOSE TISSUE Kessler Foundation | Early Phase 1 | C |
DEXTROSE Rizki Darmawan | N/A | D |
HYALURONATE Chang Gung Memorial Hospital | N/A | D |
LIDOCAINE Ankara City Hospital Bilkent | N/A | D |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →